Prostate Cancer Survival Analysis of 872 Patients in Southern Iran: A Retrospective Cohort Study

Prostate Cancer Survival Analysis of 872 Patients in Southern Iran: A Retrospective Cohort Study

Background: Prostate cancer remains one of the most common and lethal cancers among men worldwide. This study aimed to investigate the characteristics, prognostic factors, and outcomes of patients with prostate cancer who were treated and followed up in Shiraz, southern Iran over the past 12 years.M...

Full description

Bibliographic Details
Main Authors:	Mahsa Sepahvand, Alireza Salehi, Ali Omidvari, Shapour Omidvari, Mohammad Mohammadianpanah
Format:	Article
Language:	English
Published:	Shiraz University of Medical Sciences 2023-10-01
Series:	Middle East Journal of Cancer
Subjects:	prostatic neoplasms survival analysis prostate-specific antigen prognosis roc curve
Online Access:	https://mejc.sums.ac.ir/article_49207_9f167bb4f52dfb73e960bb6dda3b78e5.pdf

Similar Items

Prostate-specific antigen testing accuracy in community practice
by: Adams-Cameron Meg, et al.
Published: (2002-10-01)

Nadir prostate-specific antigen as a prognostic factor of 10-year cancer-specific survival of prostate cancer patients with bone metastases
by: Chi-Feng Hung, et al.
Published: (2022-01-01)

Prostate-specific antigen and prostate-specific antigen density cutoff points among Indonesian population suspected for prostate cancer
by: Ahmad Anies Shahab, et al.
Published: (2013-03-01)

Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screening
by: Yasuhide Kitagawa, et al.
Published: (2013-06-01)

The role of transurethral resection of the prostate for patients with an elevated prostate-specific antigen
by: Hee Ju Cho, et al.
Published: (2014-12-01)

Socioeconomic status is an independent predictor of biochemical recurrence among patients with prostate cancer who undergo radical prostatectomy
by: Victor Srougi, et al.
Published: (2011-08-01)

High Tumor Burden Predicts Poor Response to Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients
by: Yu-Ting Hsieh, et al.
Published: (2021-08-01)

Diagnostic accuracy of prostate-specific antigen below 4 ng/mL as a cutoff for diagnosing prostate cancer in a hospital setting: A systematic review and meta-analysis
by: Yan Jin, et al.
Published: (2022-05-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/− Docetaxel
by: Aurore Carrot, et al.
Published: (2022-02-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

The Impact of the Percent of Residual Prostate-Specific Antigen on Metastasis-Free Survival in Patients with Persistent Prostate-Specific Antigen after Radical Prostatectomy
by: Dan Bee Lee, et al.
Published: (2023-01-01)

Development and validation of a multi-parameter nomogram for predicting prostate cancer: a retrospective analysis from Handan Central Hospital in China
by: Libin Nan, et al.
Published: (2022-03-01)

Value of prostate specific antigen in predicting the existence of bone metastasis in scintigraphy
by: Ernani L. Rhoden, et al.
Published: (2003-04-01)

Prevalence of prostate adenocarcinoma according to race in an university hospital
by: Milton S Barros, et al.
Published: (2003-08-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

The COVID-19 pandemic's impact on prostate cancer screening and diagnosis in Korea
by: Byeong Jin Kang, et al.
Published: (2023-09-01)

Prostate-specific antigen velocity in diagnosis and prognosis of prostate cancer - a systematic review
by: Arslaan Javaeed, et al.
Published: (2020-05-01)

Predictors of survival in prostate cancer patients with bone metastasis and extremely high prostate-specific antigen levels
by: Kyo Chul Koo, et al.
Published: (2015-03-01)

Shifting the Paradigm of Testosterone Replacement Therapy in Prostate Cancer
by: Michael A. Bell, et al.
Published: (2018-05-01)

Trends of stratified prostate cancer risk in a single Korean province from 2003 to 2021: A multicenter study conducted using regional training hospital data
by: Young Hwii Ko, et al.
Published: (2023-03-01)

Initial Symptomatic Pituitary Metastasis in a Patient with Prostate Foamy Gland Carcinoma: Tailoring Safe and Effective Therapy
by: Marin Prpić, et al.
Published: (2015-01-01)

Evaluation of concordance between histopathological prognostic findings from prostate needle biopsy samples and serum prostate-specific antigen levels
by: Cengiz Kocak
Published: (2019-03-01)

Serum PSA and cure perspective for prostate cancer in males with nonpalpable tumor
by: Marcos F. Dall'Oglio, et al.
Published: (2005-10-01)

Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan
by: Chie Koizumi
Published: (2014-03-01)

CUT-OFF POINT OF PSA AND PSA DENSITY IN PROSTATE CANCER SUSPECTED PATIENTS
by: Daniel Simanjuntak, et al.
Published: (2016-03-01)

Incidental prostate cancer: a 23-year review of a tertiary care hospital
by: Abdul khalique, et al.
Published: (2023-07-01)

Ten‐year outcomes of whole‐pelvic intensity‐modulated radiation therapy for prostate cancer with regional lymph node metastasis
by: Kiyonao Nakamura, et al.
Published: (2023-04-01)

Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration
by: Annika Krystyna, et al.
Published: (2011-04-01)

Epidemiology of prostate cancer in the Asia-Pacific region
by: Peter D. Baade, et al.
Published: (2013-06-01)

Hormonal status in patients with advanced prostatic cancer on the therapy with androgen blockade
by: Vojinov Saša, et al.
Published: (2011-01-01)

Comparison of Prostate-Specific Antigen and Its Density and Prostate Health Index and Its Density for Detection of Prostate Cancer
by: Youngjun Boo, et al.
Published: (2023-07-01)

The Prostate Problem You Can’t Put Your Finger on the Normal Way: A Case of Perineal Prostate Cancer Post Transperineal Prostate Biopsy
by: Kevin Yinkit Zhuo, et al.
Published: (2023-05-01)

Epidemiological Study of Patients with Prostate Cancer in South of Iraq
by: Manal Badi Salih Al-Tmemi
Published: (2019-07-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 Patients
by: Menachem Laufer, et al.
Published: (2023-09-01)

Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population
by: V. Surya Prakash, et al.
Published: (2013-12-01)

PSA density improves the rate of prostate cancer detection in Chinese men with a PSA between 2.5-10.0 ng ml -1 and 10.1-20.0 ng ml -1 : a multicenter study
by: Yu-Rong Lin, et al.
Published: (2015-06-01)

Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure
by: Dong-Yun Kim, et al.
Published: (2023-06-01)